Chris Copple

Chris Copple is a seasoned serial entrepreneur in the biotechnology field, boasting extensive experience in both private and public companies as well as expertise in venture investments.

Currently, Chris offers his entrepreneurial services to biotechnology firms spanning from early-stage startups to those in clinical stages.

His areas of expertise encompass oncology, infectious diseases, CNS, stem cells, nanomedicines, in silico drug design/development, and other IT applications translating information into actionable knowledge.

Chris is well-versed in strategic and tactical planning, fundraising, overseeing operations, business development, forming joint ventures, regulatory affairs, manufacturing, domestic and international marketing, investor relations, public speaking, legislative affairs, and PR.

His educational background includes a Ph.D. in Cell/Cellular and Molecular Biology from The University of Birmingham, a B.Sc. (Hons) in Biological Sciences from the University of East Anglia, and further studies at The Johns Hopkins University's Carey Business School.

Throughout his career, Chris has held various roles such as CEO at Starise Ventures, Inc., Chief Operating Officer & Executive Vice President at ETX Pharma, Inc., and positions at organizations like Washington D.C. ArchAngels, ASM Resources, Inc., Neuralstem, Inc., University of Maryland Biotechnology Institute, Microfluidics, Inc., Marcel Dekker, and Cold Spring Harbor Laboratory.